Search by Drug Name, NDC or Jcode

    Internal Navigation

    HCPCS Details

    HCPC J7612
    Short Description Levalbuterol non-comp con
    Long Description Levalbuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 0.5 mg
    Pricing indicator 00
    Coverage code D
    ASC payment group code
    BETOS2 code D1G
    Action code N
    Type of service 1
    Effective date 2009-07-01
    Date Added 2005-01-01

    HCPCS/NDC Cross-Walk

    NDC HCPC Description Drug Name Labeler Name HCPCS Dosage PKG Size PKG QTY Bill Units Bill Units PKG
    00093414756 J7612 Levalbuterol non-comp con LEVALBUTEROL TEVA PHARMACEUTICALS USA, INC. 0.5 MG 0.5 30 2.5 75
    00378699393 J7612 Levalbuterol non-comp con Levalbuterol Inhalation Solution Concentrated MYLAN PHARMACEUTICALS, INC 0.5 MG 0.5 30 2.5 75
    35573044325 J7612 Levalbuterol non-comp con LEVALBUTEROL BUREL PHARMACEUTICALS 0.5 MG 3 25 0.62 15.5
    35573044425 J7612 Levalbuterol non-comp con LEVALBUTEROL BUREL PHARMACEUTICALS 0.5 MG 3 25 1.25 31.25
    35573044525 J7612 Levalbuterol non-comp con LEVALBUTEROL BUREL PHARMACEUTICALS 0.5 MG 3 25 2.5 62.5
    The ASP crosswalks are maintained by the Division of Data Analysis and Market Based Pricing to support ASP-based Medicare Part B payments only. The crosswalks are intended to help the public (including entities that submit manufacturer ASP data and providers who bill for drugs) understand which drug products (identified by NDCs) are assigned to which HCPCS billing codes. The crosswalks are not intended to be a comprehensive list of all drugs/NDCs available in the United States. The NDC to HCPCS Crosswalk also includes information on the NDC package size and the number of billable units (as defined by the HCPCS code descriptor). Comments on the file may be sent to [email protected].